FLASCO

FDA Discontinues Iclusig® REMS Program

  • FLASCO
  • August 1, 2018

FDA has removed the ICLUSIG REMS information from its website, and the ICLUSIG REMS website was deactivated by Takeda at the end of July. Takeda will continue to educate patients and physicians about the risks associated with ICLUSIG.

View the FDA approval of this REMS program discontinuation.

Who’s Online

There are no users currently online